FOLD
AMICUS THERAPEUTICS, INC.
AMICUS THERAPEUTICS, INC. (FOLD) has 16 SEC Form 4 filings (18 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Apr 27, 2026.
Insiders have net sold $1.4M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Bradley L. Campbell
- Employees:499
- HQ:Philadelphia, PA, US
- IPO:2007-05-31
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.4M
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
| Source | ||||||
|---|---|---|---|---|---|---|
| President and CEO | Sale | 22,500 | $323K | Mar 4 | SEC ↗ | |
Campbell Bradley LFirst filing | President and CEO | Sale | 75,000 | $1.1M | Jan 22 | SEC ↗ |